Lista de obras -

A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting

artículo científico publicado en 2004

A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

artículo científico publicado en 2005

A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts

artículo científico publicado en 2006

A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts

artículo científico publicado en 2004

Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease

artículo científico publicado en 2012

Benefits of cutting balloon before stenting

artículo científico publicado el 1 de noviembre de 2003

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

artículo científico publicado en 2003

Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery disease

artículo científico publicado en 2014

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

artículo científico publicado en 2011

Cardiovascular risk profiles and outcomes of Chinese living inside and outside China.

artículo científico publicado en 2010

Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment

artículo científico publicado en 2006

Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study

scientific article published on 19 February 2013

Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization

artículo científico publicado en 2016

Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure

artículo científico publicado en 2013

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

artículo científico publicado en 2006

Clopidogrel and percutaneous coronary interventions

artículo científico publicado en 2003

Clopidogrel in interventional cardiology: questions answered and questions remaining

artículo científico publicado en 2002

Comparison of Radial Artery and Saphenous Vein Graft Stenosis More Than 5 Years After Coronary Artery Bypass Grafting

artículo científico publicado en 2016

Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial)

artículo científico publicado en 2005

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

article

Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario

artículo científico publicado en 2013

Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report

artículo científico publicado en 2006

Determinants of variations in coronary revascularization practices ⬇️

artículo científico publicado el 12 de diciembre de 2011

Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation

artículo científico publicado en 2016

Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario

artículo científico publicado en 2009

Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).

artículo científico publicado en 2005

Effectiveness and safety of drug-eluting stents in Ontario.

artículo científico publicado en 2007

Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled tria

artículo científico publicado en 2014

Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial ⬇️

artículo científico publicado el 1 de febrero de 2012

Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Inf

scientific article published on 17 August 2012

Emergency coronary artery bypass surgery in the era of glycoprotein IIb/IIIa receptor antagonist use.

artículo científico publicado en 2002

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention

artículo científico publicado en 2003

Exercise-induced ST segment elevation in leads V1 to V3 due to proximal right coronary artery stenosis

scientific article published on 01 August 2005

High mortality with ST elevation myocardial infarction in a nontrial setting

artículo científico publicado en 2004

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

artículo científico publicado en 2002

Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial

artículo científico publicado en 2007

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention

artículo científico publicado en 2016

Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times

artículo científico publicado en 2019

Issues influencing development of the Canadian Cardiovascular Information Network

artículo científico publicado en 2004

Long-Term Safety and Effectiveness of Drug-Eluting Stents for the Treatment of Saphenous Vein Grafts Disease

artículo científico publicado en 2011

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

artículo científico publicado en 2004

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention

artículo científico publicado en 2002

Low rates of angiographic and clinical restenosis with the new flexible MedStent for the treatment of single discrete coronary lesions

artículo científico publicado en 2004

Management of atherothrombotic risk factors in high-risk Canadian outpatients

artículo científico publicado en 2009

Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes

artículo científico publicado en 2007

Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)

artículo científico publicado en 2018

Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

artículo científico publicado en 2010

Medical Therapy and Coronary Revascularization for Patients With Stable Coronary Artery Disease and Unclassified Appropriateness Score

artículo científico publicado en 2015

MitraClip for papillary muscle rupture in patient with cardiogenic shock

artículo científico publicado en 2014

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

artículo científico publicado en 2002

Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm

artículo científico publicado en 2006

Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease

artículo científico publicado en 2020

One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.

artículo científico publicado en 2010

Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy

artículo científico

Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients

artículo científico publicado en 2009

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

artículo científico publicado en 2007

Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice

artículo científico publicado en 2014

Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.

artículo científico publicado en 2004

Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology

artículo científico publicado en 2020

Predictors of normal coronary arteries at coronary angiography

artículo científico publicado en 2013

Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy

artículo científico publicado en 2014

Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries

artículo científico publicado en 2003

Quality of Care for Transcatheter Aortic Valve Implantation: Development of Canadian Cardiovascular Society Quality Indicators.

artículo científico publicado en 2015

Quality of life after late invasive therapy for occluded arteries

artículo científico publicado en 2009

Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study)

artículo científico publicado en 2012

Radial artery angiographic string sign: clinical consequences and the role of pharmacologic therapy

artículo científico publicado en 2006

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study

artículo científico publicado en 2012

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial

artículo científico publicado en 2006

Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).

artículo científico publicado en 2007

Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardia

artículo científico publicado en 2011

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: An ESPRIT substudy ⬇️

artículo científico publicado el 1 de enero de 2002

Reperfusion Times for Radial Versus Femoral Access in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Observations From the Cardiac Care Network Provincial Primary PCI Registry

artículo científico publicado en 2015

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

artículo científico publicado en 2010

Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspective

artículo científico publicado en 2003

Routine early angioplasty after fibrinolysis for acute myocardial infarction

artículo científico publicado en 2009

Safety and Effectiveness of Drug-Eluting and Bare-Metal Stents for Patients With Off- and On-Label Indications

artículo científico publicado en 2009

Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis

artículo científico publicado en 2008

Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses

artículo científico publicado en 2006

Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial

artículo científico publicado en 2011

Takotsubo cardiomyopathy and left ventricular outflow tract obstruction

scientific article published on 13 July 2009

The Canadian Association of Interventional Cardiology and the Canadian Cardiovascular Society joint statement on drug-eluting stents

artículo científico publicado en 2007

The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS).

artículo científico publicado en 2004

The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy alone

artículo científico publicado en 2011

The economics of adjunctive therapies in coronary angioplasty: drugs, devices, or both?

artículo científico publicado en 2004

The evaluation of a formalized queue management system for coronary angiography waiting lists

scientific article published on 01 November 2005

The impact of diabetic status on coronary artery bypass graft patency: insights from the radial artery patency study

artículo científico publicado en 2008

The long-term impact of diabetes on graft patency after coronary artery bypass grafting surgery: a substudy of the multicenter Radial Artery Patency Study

artículo científico publicado en 2014

The radial artery is protective in women and men following coronary artery bypass grafting-a substudy of the radial artery patency study

artículo científico publicado en 2018

Thrombotic thrombocytopenic purpura associated with clopidogrel: further evaluation.

artículo científico publicado en 2002

Thrombus aspiration during primary percutaneous coronary intervention is associated with reduced myocardial edema, hemorrhage, microvascular obstruction and left ventricular remodeling ⬇️

artículo científico publicado el 26 de marzo de 2012

Transcatheter Mitral Valve Edge-to-Edge Repair with the New MitraClip XTR System for Acute Mitral Regurgitation Caused by Papillary Muscle Rupture

artículo científico publicado en 2019

Triple antiplatelet therapy does not increase femoral access bleeding with vascular closure devices

artículo científico publicado en 2004

Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease

artículo científico publicado en 2019

Lista de obras de

A comparison of clinical outcomes between Canadian and American patients after nonurgent coronary stenting

A global view of atherothrombosis: baseline characteristics in the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts

A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts

Assessing the association of appropriateness of coronary revascularization and clinical outcomes for patients with stable coronary artery disease

Benefits of cutting balloon before stenting

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology/Canadian Society of Cardiac Surgery position statement on revascularization--multivessel coronary artery disease

Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".

Cardiovascular risk profiles and outcomes of Chinese living inside and outside China.

Characterizing the spectrum of in-stent restenosis: implications for contemporary treatment

Clinical outcomes and cost implications of routine early PCI after fibrinolysis: one-year follow-up of the Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI) study

Clinical outcomes in patients with stable coronary artery disease with vs. without a history of myocardial revascularization

Clinical, biochemical, and genetic predictors of coronary artery bypass graft failure

Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events

Clopidogrel and percutaneous coronary interventions

Clopidogrel in interventional cardiology: questions answered and questions remaining

Comparison of Radial Artery and Saphenous Vein Graft Stenosis More Than 5 Years After Coronary Artery Bypass Grafting

Comparison of enoxaparin versus heparin during elective percutaneous coronary intervention performed with either eptifibatide or tirofiban (the ACTION Trial)

Complementary Clinical Benefits of Coronary-Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors

Cost-effectiveness of 64-slice CT angiography compared to conventional coronary angiography based on a coverage with evidence development study in Ontario

Delivery of primary percutaneous coronary intervention for the management of acute ST segment elevation myocardial infarction: summary of the Cardiac Care Network of Ontario Consensus Report

Determinants of variations in coronary revascularization practices ⬇️

Drivers of healthcare costs associated with the episode of care for surgical aortic valve replacement versus transcatheter aortic valve implantation

Economic evaluation of drug-eluting stents compared to bare metal stents using a large prospective study in Ontario

Effect of bare metal stenting on angiographic and clinical outcomes in diabetic and nondiabetic patients undergoing percutaneous coronary intervention of nonacute occluded coronary arteries: a report from the Total Occlusion Study of Canada (TOSCA).

Effectiveness and safety of drug-eluting stents in Ontario.

Efficacy and safety of a routine early invasive strategy after fibrinolysis stratified by glycoprotein IIb/IIIa inhibitor use during percutaneous coronary intervention: a pre-specified subgroup analysis of the TRANSFER-AMI randomised controlled tria

Efficacy and safety of enoxaparin compared with unfractionated heparin in the pharmacoinvasive management of acute ST-segment elevation myocardial infarction: Insights from the TRANSFER-AMI trial ⬇️

Efficacy of early invasive management post-fibrinolysis in men versus women with ST-elevation myocardial infarction: a subgroup analysis from Trial of Routine Angioplasty and Stenting after Fibrinolysis to Enhance Reperfusion in Acute Myocardial Inf

Emergency coronary artery bypass surgery in the era of glycoprotein IIb/IIIa receptor antagonist use.

Ethics and equipoise: rationale for a placebo-controlled study design of platelet glycoprotein IIb/IIIa inhibition in coronary intervention

Exercise-induced ST segment elevation in leads V1 to V3 due to proximal right coronary artery stenosis

High mortality with ST elevation myocardial infarction in a nontrial setting

Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial

Impact of patient and target-vessel characteristics on arterial and venous bypass graft patency: insight from a randomized trial

Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention

Inequity in Access to Transcatheter Aortic Valve Replacement: A Pan-Canadian Evaluation of Wait-Times

Issues influencing development of the Canadian Cardiovascular Information Network

Long-Term Safety and Effectiveness of Drug-Eluting Stents for the Treatment of Saphenous Vein Grafts Disease

Long-term efficacy of bivalirudin and provisional glycoprotein IIb/IIIa blockade vs heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary revascularization: REPLACE-2 randomized trial

Long-term efficacy of platelet glycoprotein IIb/IIIa integrin blockade with eptifibatide in coronary stent intervention

Low rates of angiographic and clinical restenosis with the new flexible MedStent for the treatment of single discrete coronary lesions

Management of atherothrombotic risk factors in high-risk Canadian outpatients

Management patterns in relation to risk stratification among patients with non-ST elevation acute coronary syndromes

Marital status and outcomes after myocardial infarction: Observations from the Canadian Observational Antiplatelet Study (COAPT)

Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI).

Medical Therapy and Coronary Revascularization for Patients With Stable Coronary Artery Disease and Unclassified Appropriateness Score

MitraClip for papillary muscle rupture in patient with cardiogenic shock

Multi-year follow-up of abciximab therapy in three randomized, placebo-controlled trials of percutaneous coronary revascularization

Non ST segment elevation acute coronary syndromes: A simplified risk-orientated algorithm

Nonculprit Lesion Severity and Outcome of Revascularization in Patients With STEMI and Multivessel Coronary Disease

One-year costs associated with cardiovascular disease in Canada: Insights from the REduction of Atherothrombosis for Continued Health (REACH) registry.

Ontario multidetector computed tomographic coronary angiography study: field evaluation of diagnostic accuracy

Paclitaxel versus sirolimus stents in diabetic and nondiabetic patients

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial

Pharmacodynamic and clinical implications of switching between P2Y12 receptor antagonists: considerations for practice

Pre-procedural plasma levels of C-reactive protein and interleukin-6 do not predict late coronary angiographic restenosis after elective stenting.

Precautions and Procedures for Coronary and Structural Cardiac Interventions During the COVID-19 Pandemic: Guidance from Canadian Association of Interventional Cardiology

Predictors of normal coronary arteries at coronary angiography

Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapy

Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries

Quality of Care for Transcatheter Aortic Valve Implantation: Development of Canadian Cardiovascular Society Quality Indicators.

Quality of life after late invasive therapy for occluded arteries

Radial artery and saphenous vein patency more than 5 years after coronary artery bypass surgery: results from RAPS (Radial Artery Patency Study)

Radial artery angiographic string sign: clinical consequences and the role of pharmacologic therapy

Randomized trial of insulin versus usual care in reducing restenosis after coronary intervention in patients with diabetes. the STent Restenosis And Metabolism (STREAM) study

Randomized trial of percutaneous coronary intervention for subacute infarct-related coronary artery occlusion to achieve long-term patency and improve ventricular function: the Total Occlusion Study of Canada (TOSCA)-2 trial

Rationale and design of the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardial Infarction (TRANSFER-AMI).

Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis: insights from the Trial of Routine ANgioplasty and Stenting After Fibrinolysis to Enhance Reperfusion in Acute Myocardia

Relationship of creatine kinase-myocardial band release to Thrombolysis in Myocardial Infarction perfusion grade after intracoronary stent placement: An ESPRIT substudy ⬇️

Reperfusion Times for Radial Versus Femoral Access in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: Observations From the Cardiac Care Network Provincial Primary PCI Registry

Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial

Risk stratification, management and outcomes of patients with non-ST elevation acute coronary syndrome: a Canadian teaching hospital perspective

Routine early angioplasty after fibrinolysis for acute myocardial infarction

Safety and Effectiveness of Drug-Eluting and Bare-Metal Stents for Patients With Off- and On-Label Indications

Safety and effectiveness of drug-eluting stents among diabetic patients: a propensity analysis

Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses

Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial